Search

everythinglearnresearchcommunity

for

Search:↓

lncRNAs play a key role in hair follicle development, affecting cashmere quality and yield.

Understanding tissue self-organization can improve treatments for diseases and advance regenerative medicine.

Leptin, a hormone from fat cells, affects immune responses and can influence skin diseases and hair growth.

Stem cell treatment from umbilical cords reduces symptoms of atopic dermatitis and may help hair growth.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

Alopecia areata in children is caused by the immune system attacking hair follicles due to genetic factors.

Natural products and phytochemicals may help with hair regrowth, but more research is needed.

JAK inhibitors show promise for treating various skin diseases.

Alopecia areata and atopic dermatitis share immune system issues, and treatments like JAK inhibitors can help both.

Bio-nanovesicles could improve hair and skin regeneration by delivering important molecules to repair and heal.

Alopecia areata involves immune system issues and specific cell types that disrupt hair growth, leading to hair loss.

NLRP3 helps control inflammation and repair in wound healing, making it a potential target for treatment.

Dupilumab can cause psoriasis in some patients.

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.

Cellular senescence can both hinder and promote hair growth, suggesting new ways to treat hair loss.

Upadacitinib successfully regrew hair in a child with alopecia universalis and specific genetic mutations.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

Activating Tgr5 may help treat hair loss and bone loss.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Mesenchymal Stem Cell therapy shows promise for treating hair loss in Alopecia Areata.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Key genes and pathways involved in thyroid eye disease were identified, aiding potential treatment and diagnosis.

SARS-CoV-2 may worsen IPF due to shared genes and pathways, suggesting potential drug targets.

PPARα agonists may help treat alopecia areata by reducing inflammation.

Chronic skin diseases and metabolic syndrome are linked by shared inflammation pathways.

Dupilumab for skin problems might reactivate hair loss in some patients.

lncRNAs are important for understanding and treating skin diseases.

Low humidity changes skin gene expression, but emollients can help manage these changes.

The study suggests that hypothyroidism may cause alopecia areata.